Meritain Health policies, page 102

Search Meritain Health's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

5,481 public policies Substrate tracks for Meritain Health, by title.

Meritain Health policies
PolicyDetailsCodesSource
Nasolacrimal Duct Obstruction: Treatments0420 · Commercial14Original policy ↗
Nayzilam PA with Limit Policy 3102-C UDR 06-20233102-C · Commercial—Original policy ↗
Negative Pressure Wound Therapy0334 · Commercial40Original policy ↗
Neonatal Hyperbilirubinemia0332 · Commercial17Original policy ↗
Nerlynx SGM 2178-A P20262178-A · Commercial—Original policy ↗
Nerve Grafting and Reconstruction: Selected Indications0416 · Commercial14Original policy ↗
Neulasta and pegfilgrastim biosimilars 1931-A SGM P2022a1931-A · Commercial—Original policy ↗
Neuralgia Inducing Cavitational Osteonecrosis (NICO) and Ultrasonograph Bone Densitometer to Detect NICO0642 · Commercial15Original policy ↗
Ninlaro 2372-A SGM P20222372-A · Commercial—Original policy ↗
Ninlaro SGM 2372-A P20252372-A · Commercial—Original policy ↗
Nitric Oxide, Inhalational (INO)0518 · Commercial6Original policy ↗
Non-invasive Negative Pressure Ventilation: Body Ventilators and Poncho Wrap0298 · Commercial7Original policy ↗
Non-myeloablative Hematopoietic Cell Transplantation (Mini-Allograft / Reduced Intensity Conditioning Transplant)0634 · Commercial19Original policy ↗
Noninvasive Tests for Hepatic Fibrosis0690 · Commercial28Original policy ↗
Northera 2020-A SGM P2021P2021 · Commercial—Original policy ↗
Nuedexta PA Policy 870-A, 599-A 04-2022870-A, 599-A · Commercial—Original policy ↗
Nuvigil PA with Limit 534-C P01-2026534-C P01-2026 · Commercial—Original policy ↗
Obesity Surgery0157 · Commercial70Original policy ↗
Obizur 1948-A SGM P20241948-A · Commercial—Original policy ↗
Obsolete and Unreliable Tests and Procedures0438 · Commercial42Original policy ↗
Obstructive Sleep Apnea in Adults0004 · Commercial174Original policy ↗
Occupational Therapy0250 · Commercial10Original policy ↗
Odactra PA Policy 1610-A UDR 02-20241610-A · Commercial—Original policy ↗
Odomzo 1786-A SGM P20241786-A · Commercial—Original policy ↗
Ofev 1882-A SGM P20221882-A · Commercial—Original policy ↗
Omalizumab0670 · Commercial46Original policy ↗
Omvoh 6239-A SGM P20236239-A · Commercial—Original policy ↗
Onfi, Sympazan PA Policy 718-A 06-2022 v2718-A · Commercial—Original policy ↗
Open Air, Low Field Strength, and Positional Magnetic Resonance Imaging (MRI) Units0093 · Commercial16Original policy ↗
Opioid Containing Cough and Cold Products Limit, Post PA 4428-HJ P02-20264428-HJ P02-2026 · Commercial—Original policy ↗
Opioids IR - 7-Day Combo Products - Acute Pain Duration Limit1358-E · Commercial—Original policy ↗
Optic Nerve and Retinal Imaging Methods0344 · Commercial15Original policy ↗
Optic Nerve Decompression Surgery0415 · Commercial2Original policy ↗
Opzelura PA with Limit Policy 5018-C UDR 04-20245018-C · Commercial—Original policy ↗
Oral Cancer Screening Adjuncts Policy (045)045 · Effective Mar 13, 2026 · Commercial1Original policy ↗
Orenitram SGM 1643-A P20251643-A · Commercial—Original policy ↗
Orilissa PA 2634-A P01-20262634-A · Commercial—Original policy ↗
Orilissa PA Policy 2634-A UDR 01-20242634-A · Commercial—Original policy ↗
Orkambi SGM 1885-A P20251885-A · Commercial—Original policy ↗
Orladeyo SGM 4400-A P2024b_R4400-A · Commercial—Original policy ↗
Orthognathic Surgery0095 · Commercial72Original policy ↗
Orthopoxvirus Vaccines0644 · Commercial9Original policy ↗
Osteochondral Autografts (Mosaicplasty, OATS)0637 · Commercial16Original policy ↗
Outpatient Medical Self-Care Programs0169 · Commercial—Original policy ↗
Oxervate SGM 2869-A P20252869-A · Commercial—Original policy ↗
Palivizumab (Synagis)0318 · Commercial52Original policy ↗
Pancreas Kidney Transplantation0587 · Commercial23Original policy ↗
Pancreas Transplantation Alone (PTA) and Islet Cell Transplantation0601 · Commercial19Original policy ↗
Pancreaticoduodenectomy (Whipple Resection)0365 · Commercial13Original policy ↗
Parenteral Immunoglobulins0206 · Commercial107Original policy ↗

Back to Meritain Health

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.